ViaDerma, Inc. Stock

VDRM

US92555K1016

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 12:32:26 2026-07-16 EDT			5-day change	1st Jan Change
0.000400 ^USD	0.00%		0.00%	+100.00%

25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	CI
24-08-13	ViaDerma, Inc. Announces Commencement of the Registration Process in Kenya, Namibia, and Tanzania for Strategic Expansion into East and Southern Africa	CI

ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Companyâ€™s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Companyâ€™s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Companyâ€™s subsidiary is ViaDerma, II Inc.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-07-16	US$0.000400	0.00%	110,000
26-07-15	US$0.000400	0.00%	200
26-07-13	US$0.000400	0.00%	825,230
26-07-10	US$0.000400	0.00%	3,000
26-07-09	US$0.000400	0.00%	40,000

Delayed Quote OTC Markets

More quotes

Stock Market
Stocks
VDRM Stock

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	6.31M 5.51M 5.1M 4.68M 8.85M 608M 9.01M 60.79M 23.88M 297M 23.68M 23.16M 1.02B	P/E 2015	10.7x	P/E 2016	-3.3x
Enterprise Value	6.6M 5.77M 5.34M 4.9M 9.27M 636M 9.43M 63.65M 25M 311M 24.79M 24.25M 1.07B	EV / Sales 2015	1.5x	EV / Sales 2016	3.63x
Free-Float	99%	Yield 2015 *	-	Yield 2016	-

25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	CI
24-08-13	ViaDerma, Inc. Announces Commencement of the Registration Process in Kenya, Namibia, and Tanzania for Strategic Expansion into East and Southern Africa	CI
24-08-13	ViaDerma, Inc. Announces Shipment of 500,000 Units of its Product to Nigeria	CI
24-08-01	ViaDerma, Inc. Finalizes Distribution Agreements in Dubai	CI
23-03-16	ViaDerma, Inc. Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product	CI
23-03-08	ViaDerma Announces Intent to Launch New Minoxidil Hair Regrowth Product	CI
22-09-15	ViaDerma, Inc. Successfully Completes Quality Control Testing of Its New Vitastem Products	CI
21-10-04	ViaDerma, Inc. Set to Launch Two New and Improved Versions of Its Flagship Product, Vitastem and Vitastem Ultra	CI
21-06-24	ViaDerma, Inc. Provides Updates on Current Business Activities	CI
21-06-02	ViaDerma, Inc. Announces Expansion of Its Current Licensing Agreement	CI
21-05-13	ViaDerma, Inc. Nearing Initial Order from Large Hospital Network	CI
21-04-08	ViaDerma, Inc. Provides Revenue Guidance for the First Quarter of 2021	CI
21-01-21	ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States	CI

25-07-16	ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes	AQ
25-06-04	ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance	AQ
25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	AQ
24-12-10	ViaDerma Announces Significant 2024 Achievements and International Expansion	AQ
24-10-03	ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth	AQ

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0.01
3 years	0		0.02
5 years	0		0.03
10 years	0		0.08

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VIADERMA, INC.	0.00%	0.00%	-94.29%	-96.04%	493K
LONZA GROUP AG	-1.07%	-1.27%	+0.95%	+5.66%	50.35B
REVOLUTION MEDICINES, INC.	-2.85%	-6.25%	+366.61%	+572.09%	39.21B
BEONE MEDICINES AG	+1.98%	+4.82%	+13.71%	+61.68%	34.6B
IQVIA HOLDINGS INC.	+1.78%	+0.73%	+32.68%	-4.80%	34.52B
CELLTRION, INC.	+0.06%	+1.56%	+4.41%	+27.42%	27.05B
ASCENDIS PHARMA A/S	-3.27%	-5.67%	-	-	16.68B
MEDPACE HOLDINGS, INC.	+1.64%	+0.45%	+70.86%	+121.18%	15.11B
EUROFINS SCIENTIFIC SE	+0.29%	+1.02%	+14.95%	+17.80%	13.85B
ICON PUBLIC LIMITED COMPANY	-1.21%	+0.73%	+18.02%	-30.96%	13.18B
Average	-0.26%	+0.11%	+47.55%	+74.89%	24.46B
Weighted average by Cap.	-0.31%	+0.41%	+77.50%	+118.91%

ViaDerma, Inc. Stock

Stocks

VDRM

US92555K1016

Biotechnology & Medical Research

Valuation: ViaDerma, Inc.

Chart: ViaDerma, Inc.

Latest news : ViaDerma, Inc.

Press Releases: ViaDerma, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: ViaDerma, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

	2015	2016
Net sales	192K 168K 155K 142K 269K 18.48M 274K 1.85M 726K 9.02M 720K 704K 31.16M	252K 220K 204K 187K 354K 24.28M 360K 2.43M 954K 11.86M 946K 926K 40.94M
Net income	27.12K 23.71K 21.92K 20.12K 38.08K 2.61M 38.74K 261K 103K 1.28M 102K 99.61K 4.41M	-122K -106K -98.46K -90.35K -171K -11.74M -174K -1.17M -461K -5.73M -457K -447K -19.79M
Net Debt	288K 252K 233K 214K 405K 27.77M 412K 2.78M 1.09M 13.56M 1.08M 1.06M 46.82M	297K 259K 240K 220K 417K 28.6M 424K 2.86M 1.12M 13.97M 1.11M 1.09M 48.21M